ZLAB
Zai Lab Limited
stockNASDAQADR
zai lab is a biopharmaceutical company dedicated to discovering, developing and commercializing innovative medicines. our vision is to address the largest unmet medical needs and transform patients' lives around the world. we take a unique approach to combine both in-licensed products and internal r&d; to achieve a rich pipeline. we believe our drug candidates can be truly disease modifying and bring significant benefits to patients. the company was founded in 2013 by a group of industry veterans. the founders are known as pioneers in china's fast advancing biotech industry with a proven track record for successful chinese cfda and us fda filings and approvals. our senior management team introduced fast regulatory approval pathways in china and developed a variety of partnership models with multinational pharmaceutical companies. we endeavor to conduct world class clinical development in china and beyond. zai lab has strong backing from a leading group of healthcare investors. our inve
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 25.69 | 2026-09-28 | -5.29% | -6.433 |
| 1M | 26.23 | 2026-09-04 | -7.24% | 0.773 |
| 3M | 19.08 | 2026-07-06 | +27.52% | 1.261 |
| 6M | 20.50 | 2026-04-06 | +18.68% | 1.005 |
| 1Y | 33.75 | 2025-10-03 | -27.91% | 1.023 |
| 2Y | 26.36 | 2024-10-04 | -7.70% | — |
| 5Y | 102.50 | 2021-10-04 | -76.26% | 1.161 |
Zai Lab Limited (NASDAQ:ZLAB) stock price today is $24.33, and today's volume is 951,847. ZLAB is down 4.588% today. The 30 day average volume is 850,433. ZLAB market cap is $2.73B with 112.27M shares outstanding.